Los Angeles Capital Management LLC Ptc Therapeutics, Inc. Transaction History

Los Angeles Capital Management LLC

  • $24.2 Billion
  • Q4 2024

A detailed history of Los Angeles Capital Management LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 15,130 shares of PTCT stock, worth $765,124. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,130
Previous 15,130 -0.0%
Holding current value
$765,124
Previous $561,000 21.57%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024
BUY
$30.39 - $37.66 $131,436 - $162,879
4,325 Added 40.03%
15,130 $561,000
Q2 2024

Aug 05, 2024
BUY
$24.69 - $40.12 $123 - $200
5 Added 0.05%
10,805 $330,000
Q1 2024

Apr 05, 2024
BUY
$24.15 - $31.95 $48,879 - $64,666
2,024 Added 23.06%
10,800 $314,000
Q4 2023

Feb 06, 2024
BUY
$18.07 - $29.37 $158,582 - $257,751
8,776 New
8,776 $241,000
Q2 2023

Aug 03, 2023
BUY
$40.4 - $59.1 $59,266 - $86,699
1,467 Added 29.84%
6,383 $259,000
Q1 2023

May 04, 2023
BUY
$38.16 - $48.86 $187,594 - $240,195
4,916 New
4,916 $238,000
Q2 2021

Aug 05, 2021
SELL
$37.95 - $49.37 $202,349 - $263,240
-5,332 Closed
0 $0
Q1 2021

May 05, 2021
SELL
$46.8 - $68.92 $46,566 - $68,575
-995 Reduced 15.73%
5,332 $252,000
Q4 2020

Feb 04, 2021
SELL
$47.96 - $67.64 $460,799 - $649,885
-9,608 Reduced 60.29%
6,327 $386,000
Q3 2020

Nov 02, 2020
SELL
$45.41 - $57.07 $166,518 - $209,275
-3,667 Reduced 18.71%
15,935 $745,000
Q2 2020

Aug 05, 2020
BUY
$42.56 - $54.98 $37,112 - $47,942
872 Added 4.66%
19,602 $994,000
Q1 2020

May 04, 2020
BUY
$32.37 - $59.36 $415,404 - $761,766
12,833 Added 217.62%
18,730 $836,000
Q4 2019

Feb 07, 2020
BUY
$32.22 - $50.07 $190,001 - $295,262
5,897 New
5,897 $283,000
Q3 2019

Nov 07, 2019
SELL
$33.82 - $48.17 $192,875 - $274,713
-5,703 Closed
0 $0
Q2 2019

Jul 29, 2019
BUY
$35.42 - $45.0 $202,000 - $256,635
5,703 New
5,703 $257,000
Q1 2019

Apr 25, 2019
SELL
$28.09 - $39.49 $247,838 - $348,420
-8,823 Closed
0 $0
Q4 2018

Feb 11, 2019
SELL
$29.83 - $46.51 $19,986 - $31,161
-670 Reduced 7.06%
8,823 $303,000
Q3 2018

Nov 05, 2018
BUY
$33.9 - $47.77 $321,812 - $453,480
9,493 New
9,493 $446,000
Q4 2017

Feb 05, 2018
SELL
$15.14 - $20.89 $173,504 - $239,399
-11,460 Closed
0 $0
Q3 2017

Nov 06, 2017
BUY
$16.81 - $21.61 $192,642 - $247,650
11,460
11,460 $229,000

Others Institutions Holding PTCT

# of Institutions
257
Shares Held
77.3M
Call Options Held
179K
Put Options Held
536K
View Full List

About PTC THERAPEUTICS, INC.

PTCT Quotes by TradingView
  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.62B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email